MSN Laboratories Pvt. Ltd. urged the Federal Circuit to reconsider a three-judge panel’s January ruling that revived a patent for Novartis AG’s blockbuster heart-disease drug Entresto.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback